BMB Reports : eISSN 1976-670X

Cited by CrossRef (24)

  1. Ying Liu, Hao Ai. Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024;1879:189192
    https://doi.org/10.1016/j.bbcan.2024.189192
  2. Chaoyan Yue, Chunyi Zhang, Chunmei Ying, Hua Jiang. Diabetes associated with cervical carcinoma among high-risk HPV-infected patients with cytologically diagnosed high grade squamous intraepithelial lesion. Front. Endocrinol. 2022;13
    https://doi.org/10.3389/fendo.2022.993785
  3. Gang Hu, Yixuan Zheng, Essam H. Houssein, Guo Wei. GSRPSO: A multi-strategy integrated particle swarm algorithm for multi-threshold segmentation of real cervical cancer images. Swarm and Evolutionary Computation 2024;91:101766
    https://doi.org/10.1016/j.swevo.2024.101766
  4. Pengbin Ping, Juan Li, Hongbin Lei, Xiaoying Xu. Fatty acid metabolism: A new therapeutic target for cervical cancer. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1111778
  5. Amir Akdam, Liel Van Mil, Yossi Tzur, Ido Laskov, Dan Grisaru, Eduardo Schejter, Nadav Michaan. Human Papilloma Virus Typing as a Triage Tool for Women with Postcoital Bleeding: A Retrospective Cohort Study. Journal of Women's Health 2024;33:734
    https://doi.org/10.1089/jwh.2023.0616
  6. Jing Zeng, Wei Jiang, Kemin Li, Mengpei Zhang, Jinghong Chen, Yuanqiong Duan, Qingli Li, Rutie Yin. Clinical and pathological characteristics of cervical clear cell carcinoma in patients not exposed to diethylstilbestrol: a comprehensive analysis of 49 cases. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1430742
  7. Peiyu Mao, Chen Zhang, Xinyan Wang, Huadi Yang. Copious vaginal discharge finally diagnosed as cervical adenocarcinoma: A case report. 2023;102:e33614
    https://doi.org/10.1097/MD.0000000000033614
  8. Lingyu Lei, Lin Zhang, Yahong Zheng, Wei Ma, Fang Liu, Dongmei Li, Keming Chen, Yong Zeng. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study. BMC Cancer 2024;24
    https://doi.org/10.1186/s12885-024-12342-2
  9. Isadora Oliveira Ansaloni Pereira, Nayara Nascimento Toledo Silva, Angelica Alves Lima, Glenda Nicioli da Silva. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review. Environ and Mol Mutagen 2024;65:143
    https://doi.org/10.1002/em.22591
  10. Zsuzsanna Schelz, Hiba F. Muddather, Fatemeh Sheihaki Jaski, Noémi Bózsity, István Zupkó. An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer. CIMB 2024;46:6566
    https://doi.org/10.3390/cimb46070391
  11. David Holthaus, Christoph Rogmans, Ina Gursinski, Alvaro Quevedo-Olmos, Marzieh Ehsani, Mandy Mangler, Inken Flörkemeier, Jörg P. Weimer, Thomas F. Meyer, Nicolai Maass, Dirk O. Bauerschlag, Nina Hedemann. Inhibition of ADAM17 increases the cytotoxic effect of cisplatin in cervical spheroids and organoids. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1432239
  12. Roland Lengkey, Ray Soetadji, Ardo Sanjaya. Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review). World Acad Sci J 2024;6
    https://doi.org/10.3892/wasj.2024.263
  13. Lara Kokemüller, Dhanya Ramachandran, Peter Schürmann, Robert Geffers, Matthias Jentschke, Gerd Böhmer, Hans‐Georg Strauß, Christine Hirchenhain, Monika Schmidmayr, Florian Müller, Peter A. Fasching, Alexander Luyten, Norman Häfner, Peter Hillemanns, Thilo Dörk. Germline variants of homology‐directed repair or mismatch repair genes in cervical cancer. Intl Journal of Cancer 2025;156:700
    https://doi.org/10.1002/ijc.35221
  14. Alexandra D. Michel, Holly B. Fontenot, Lindsay Fuzzell, Naomi C. Brownstein, Paige Lake, Susan T. Vadaparampil, Rebecca B. Perkins. Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Cancer 2024;130:2325
    https://doi.org/10.1002/cncr.35269
  15. Yuanhong Zhou, Yan Xie, Youzheng Luo, Shuling Wang, Qing Han, Qiang Liu. SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway in vitro. Oncol Rep 2024;52
    https://doi.org/10.3892/or.2024.8763
  16. Yutai Zhao, Lei Xu, Cong Peng, Jie Deng, Chaolin Huang, Ling Lu. Clinical and prognostic significance of Hec1 expression in patients with Cervical Cancer. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1438734
  17. Mei Meng, Yan Guo, Yu Chen, Xu Li, Bin Zhang, Zhijia Xie, Juntao Liu, Zhe Zhao, Yuxi Liu, Tong Zhang, Yingnan Qiao, Bingxue Shang, Quansheng Zhou. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways. Cell Oncol. 2024;47:657
    https://doi.org/10.1007/s13402-023-00891-w
  18. Md Tamzid Hossain Tanim, Sudipta Deb Nath, Sumaiya Farah Khan, Abira Khan, Abu Ashfaqur Sajib. Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs. Cancer Treatment and Research Communications 2024;39:100808
    https://doi.org/10.1016/j.ctarc.2024.100808
  19. R. Swathi Sarma, T. S. Premalatha, Kiran Kulkarni, Geeta Acharya, Vishakha Bidkar, Gayatri Ravikumar. Serous Carcinoma of Uterine Cervix: A Clinicopathological Dilemma. Indian J Gynecol Oncolog 2025;23
    https://doi.org/10.1007/s40944-024-00936-4
  20. Yan Ma, Qian-Qian Yang, Dong-Mei Gu, Xiao Yuan, Yu-Hong Wang, Ling-Chuan Guo. Canadine inhibits epithelial mesenchymal transformation of HPV-negative cervical cancer. Tissue Barriers 2024;12
    https://doi.org/10.1080/21688370.2023.2256641
  21. Lei Qin, Dan Li, Zhihui Wang, Jianyun Lan, Chunrong Han, Jing Mei, Jianxiang Geng. Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens. Front. Public Health 2024;12
    https://doi.org/10.3389/fpubh.2024.1421774
  22. Nika Vučković, Karin Hoppe-Seyler, Angelika B. Riemer. Characterization of DoTc2 4510—Identifying HPV16 Presence in a Cervical Carcinoma Cell Line Previously Considered to Be HPV-Negative. Cancers 2023;15:3810
    https://doi.org/10.3390/cancers15153810
  23. L. A. Klyukina, E. A. Sosnova, A. A. Ishchenko, M. M. Davydov. The possibilities of predicting the individual risk of cervical cancer in women of reproductive age using mathematical modeling. Opuholi ženskoj reproduktivnoj sistemy 2024;20:90
    https://doi.org/10.17650/1994-4098-2024-16-2-90-98
  24. Paula Cristina de Vasconcelos, Tulio Resende Freitas, Lara Verônica de Araújo Lopes, Larissa Rodrigues Peixoto, Marcelo Pascoal Xavier, Anna Carolina Cançado Figueiredo, Karolina Lopes Dias, Jaqueline Germano de Oliveira, Paulo Guilherme de Oliveira Salles, Annamaria Ravaro Vago, Adriano de Paula Sabino, Maria Gabrielle de Lima Rocha. RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions. Biomarkers in Medicine 2024;18:771
    https://doi.org/10.1080/17520363.2024.2394384